Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Sep. 30, 2014 | Nov. 14, 2014 | |
Document And Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'MADISON EXPLORATIONS, INC. | ' |
Entity Central Index Key | '0001318268 | ' |
Document Type | '10-Q | ' |
Document Period End Date | 30-Sep-14 | ' |
Amendment Flag | 'false | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Entity Common Stock, Shares Outstanding | ' | 113,020,000 |
Document Fiscal Period Focus | 'Q3 | ' |
Document Fiscal Year Focus | '2014 | ' |
Consolidated_Interim_Balance_S
Consolidated Interim Balance Sheets (Unaudited) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
CURRENT ASSETS | ' | ' |
Cash | $6,408 | $9,941 |
Total Current Assets | 6,408 | 9,941 |
Technology assets - Note 4 | 50,000 | ' |
Total Assets | 56,408 | 9,941 |
CURRENT LIABILITIES | ' | ' |
Accounts payable and accrued liabilities | 17,387 | 31,842 |
Notes Payable and accrued interest - Note 5 | 107,219 | 80,310 |
Convertible notes payable - Note 8 | 91,583 | 76,000 |
Related party advance - Note 6 | 261 | 261 |
TOTAL LIABILITIES | 216,450 | 188,413 |
STOCKHOLDERS' DEFICIENCY | ' | ' |
Common Stock - Note 7 Par Value:$0.0001 Authorized 500,000,000 shares Issued and outstanding: 113,020,000 shares | 113,020 | 113,020 |
Additional Paid in Capital | 97,882 | 72,882 |
Shares authorized for issue, but not issued - Note 4 | 50,000 | ' |
Accumulated other comprehensive loss | -4,243 | -5,814 |
Accumulated deficit during exploration stage | -416,701 | -358,560 |
Total stockholders' deficiency | -160,042 | -178,472 |
Total liabilities and stockholders' deficiency | $56,408 | $9,941 |
Consolidated_Interim_Balance_S1
Consolidated Interim Balance Sheets (Unaudited) (Parenthetical) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
Statement of Financial Position [Abstract] | ' | ' |
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 500,000,000 | 500,000,000 |
Common stock, shares issued | 113,020,000 | 113,020,000 |
Common stock, shares outstanding | 113,020,000 | 113,020,000 |
Consolidated_Interim_Statement
Consolidated Interim Statements of Operations (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | 195 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | |
Income Statement [Abstract] | ' | ' | ' | ' | ' |
Revenues | $0 | $0 | $0 | $0 | $144,000 |
Operating expenses | ' | ' | ' | ' | ' |
Exploration and development | ' | ' | ' | ' | 109,040 |
General and administrative | 15,229 | 3,543 | 39,077 | 10,684 | 325,050 |
Operating expenses, total | 15,229 | 3,543 | 39,077 | 10,684 | 434,090 |
Income (loss) before other expense | -15,229 | -3,543 | -39,077 | -10,684 | -290,090 |
Other expense - interest | -7,343 | -5,363 | -19,064 | -16,838 | -126,611 |
Net loss | -22,572 | -8,906 | -58,141 | -27,522 | -416,701 |
Other Comprehensive income (loss) | ' | ' | ' | ' | ' |
Translation gain (loss) | 1,672 | -780 | 1,571 | 1,283 | -4,243 |
Total comprehensive loss | ($20,900) | ($9,686) | ($56,570) | ($26,239) | ($420,944) |
Net loss per share - Basic and diluted | $0 | $0 | $0 | $0 | ' |
Average number of shares of common stock outstanding | 113,020,000 | 113,020,000 | 113,020,000 | 113,020,000 | ' |
Consolidated_Interim_Statement1
Consolidated Interim Statements of Stockholders' Equity (Deficiency) (Unaudited) (USD $) | Common Shares [Member] | Additional Paid-In Capital [Member] | Accumulated Other Comprehensive Income [Member] | Deficit Accumulated During The Exploration Stage [Member] | Total |
Balance at Jun. 15, 1998 | ' | ' | ' | ' | ' |
Balance, shares at Jun. 15, 1998 | ' | ' | ' | ' | ' |
Issuance of common stock | 53,750 | -53,320 | ' | ' | 430 |
Issuance of common stock, shares | 53,750,000 | ' | ' | ' | ' |
Net loss and comprehensive loss | ' | ' | ' | ' | ' |
Balance at Dec. 31, 1999 | 53,750 | -53,320 | ' | ' | 430 |
Balance, shares at Dec. 31, 1999 | 53,750,000 | ' | ' | ' | ' |
Net loss and comprehensive loss | ' | ' | ' | ' | ' |
Balance at Dec. 31, 2000 | 53,750 | -53,320 | ' | ' | 430 |
Balance, shares at Dec. 31, 2000 | 53,750,000 | ' | ' | ' | ' |
Net loss and comprehensive loss | ' | ' | ' | ' | ' |
Balance at Dec. 31, 2001 | 53,750 | -53,320 | ' | ' | 430 |
Balance, shares at Dec. 31, 2001 | 53,750,000 | ' | ' | ' | ' |
Net loss and comprehensive loss | ' | ' | ' | ' | ' |
Balance at Dec. 31, 2002 | 53,750 | -53,320 | ' | ' | 430 |
Balance, shares at Dec. 31, 2002 | 53,750,000 | ' | ' | ' | ' |
Balance at Dec. 31, 2003 | 53,750 | -53,320 | ' | ' | 430 |
Balance, shares at Dec. 31, 2003 | 53,750,000 | ' | ' | ' | ' |
Issuance of common stock | 59,070 | -58,598 | ' | ' | 472 |
Issuance of common stock, shares | 59,070,000 | ' | ' | ' | ' |
Capital contribution | ' | 5,000 | ' | ' | 5,000 |
Foreign currency adjustments | ' | ' | -2,554 | ' | -2,554 |
Net Loss | ' | ' | ' | -49,088 | -49,088 |
Balance at Dec. 31, 2004 | 112,820 | -106,918 | -2,554 | -49,088 | -45,740 |
Balance, shares at Dec. 31, 2004 | 112,820,000 | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | -444 | ' | -444 |
Net Loss | ' | ' | ' | -48,720 | -48,720 |
Balance at Dec. 31, 2005 | 112,820 | -106,918 | -2,998 | -97,808 | -94,904 |
Balance, shares at Dec. 31, 2005 | 112,820,000 | ' | ' | ' | ' |
Issuance of common stock | 200 | 49,800 | ' | ' | 50,000 |
Issuance of common stock, shares | 200,000 | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | -1,297 | ' | -1,297 |
Net Loss | ' | ' | ' | -38,511 | -38,511 |
Balance at Dec. 31, 2006 | 113,020 | -57,118 | -4,295 | -136,319 | -84,712 |
Balance, shares at Dec. 31, 2006 | 113,020,000 | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | -3,445 | ' | -3,445 |
Net Loss | ' | ' | ' | 24,651 | 24,651 |
Balance at Dec. 31, 2007 | 113,020 | -57,118 | -7,740 | -111,668 | -63,506 |
Balance, shares at Dec. 31, 2007 | 113,020,000 | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | 5,639 | ' | 5,639 |
Convertible debt - Note 8 | ' | 40,000 | ' | ' | 40,000 |
Net Loss | ' | ' | ' | -29,696 | -29,696 |
Balance at Dec. 31, 2008 | 113,020 | -17,118 | -2,101 | -141,364 | ' |
Balance, shares at Dec. 31, 2008 | 113,020,000 | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | -4,578 | ' | -4,578 |
Net Loss | ' | ' | ' | -37,798 | -37,798 |
Balance at Dec. 31, 2009 | 113,020 | -17,118 | -6,679 | -179,162 | -89,939 |
Balance, shares at Dec. 31, 2009 | 113,020,000 | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | -1,716 | ' | -1,716 |
Convertible debt - Note 8 | ' | 20,000 | ' | ' | 20,000 |
Net Loss | ' | ' | ' | -37,816 | -37,816 |
Balance at Dec. 31, 2010 | 113,020 | 2,882 | -8,395 | -216,978 | -109,471 |
Balance, shares at Dec. 31, 2010 | 113,020,000 | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | 768 | ' | 768 |
Convertible debt - Note 8 | ' | 20,000 | ' | ' | 20,000 |
Net Loss | ' | ' | ' | -48,608 | -48,608 |
Balance at Dec. 31, 2011 | 113,020 | 22,882 | -7,627 | -265,586 | -137,311 |
Balance, shares at Dec. 31, 2011 | 113,020,000 | ' | ' | ' | ' |
Capital contribution | ' | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | -857 | ' | -857 |
Convertible debt - Note 8 | ' | 25,000 | ' | ' | 25,000 |
Net Loss | ' | ' | ' | -52,606 | -52,606 |
Balance at Dec. 31, 2012 | 113,020 | 47,882 | -8,484 | -318,192 | -165,774 |
Balance, shares at Dec. 31, 2012 | 113,020,000 | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | 2,670 | ' | 2,670 |
Convertible debt - Note 8 | ' | 25,000 | ' | ' | 25,000 |
Net Loss | ' | ' | ' | -40,368 | -40,368 |
Balance at Dec. 31, 2013 | 113,020 | 72,882 | -5,814 | -358,560 | -178,472 |
Balance, shares at Dec. 31, 2013 | 113,020,000 | ' | ' | ' | ' |
Capital contribution | ' | ' | ' | ' | ' |
Foreign currency adjustments | ' | ' | 1,571 | ' | 1,571 |
Convertible debt - Note 8 | ' | 25,000 | ' | ' | 25,000 |
Shares issued for technology assets - Note - 4 | 5,000 | 45,000 | ' | ' | 50,000 |
Shares issued for technology assets - Note - 4, shares | 5,000,000 | ' | ' | ' | ' |
Net Loss | ' | ' | ' | -58,141 | -58,141 |
Balance at Sep. 30, 2014 | $118,020 | $142,882 | ($4,243) | ($416,701) | ($160,042) |
Balance, shares at Sep. 30, 2014 | 118,020,000 | ' | ' | ' | ' |
Consolidated_Interim_Statement2
Consolidated Interim Statements of Cash Flows (Unaudited) (USD $) | 9 Months Ended | 195 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | |
Cash Flows from operating activities: | ' | ' | ' |
Net loss | ($58,141) | ($27,522) | ($416,701) |
Amortization of convertible debt discount recorded as interest | 15,583 | 14,250 | 91,583 |
Accrued interest on notes payable | 3,480 | 2,588 | 32,315 |
Changes assets and liabilities | ' | ' | ' |
Accounts payable and accruals | -14,455 | -4,017 | 17,387 |
Net cash used in operating activities | -53,533 | -14,701 | -275,416 |
Cash Flows From Investing Activities | ' | ' | ' |
Net cash provided (used in) investing activities | ' | ' | ' |
Cash Flows from financing activities: | ' | ' | ' |
Issuance of common stock | ' | ' | 113,020 |
Capital contribution | ' | ' | -57,118 |
Notes payable | 25,000 | ' | 70,661 |
Proceeds of convertible notes payable | 25,000 | 25,000 | 155,000 |
Related Party advances | ' | -300 | 261 |
Net Cash provided by (used in) financing activities | 50,000 | 24,700 | 281,824 |
Net increase (decrease) in cash | -3,533 | 9,999 | 6,408 |
Cash, beginning of period | 9,941 | 3,969 | ' |
Cash, end of period | 6,408 | 13,968 | 6,408 |
SUPPLEMENTAL DISCLOSURE | ' | ' | ' |
Interest | 19,063 | 16,838 | 126,611 |
Taxes paid | ' | ' | ' |
5,000,000 shares authorized but not issued for technology assets. Note - 4 | $50,000 | ' | ' |
Consolidated_Interim_Statement3
Consolidated Interim Statements of Cash Flows (Parenthetical) | Sep. 30, 2014 |
Statement of Cash Flows [Abstract] | ' |
Shares authorized but not issued for technology assets | 5,000,000 |
Interim_Reporting
Interim Reporting | 9 Months Ended | |
Sep. 30, 2014 | ||
Interim Reporting | ' | |
Interim Reporting | ' | |
Note 1 | Interim Reporting | |
While the information presented in the accompanying interim nine months consolidated financial statements is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America. These interim financial statements follow the same accounting policies and methods of their application as the Company’s December 31, 2013 annual consolidated financial statements. All adjustments are of a normal recurring nature. It is suggested that these interim financial statements be read in conjunction with the Company’s December 31, 2013 annual financial statements. Operating results for the nine months ended September 30, 2014 are not necessarily indicative of the results that can be expected for the year ended December 31, 2014. |
Nature_and_Continuance_of_Oper
Nature and Continuance of Operations | 9 Months Ended | |
Sep. 30, 2014 | ||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' | |
Nature and Continuance of Operations | ' | |
Note 2 | Nature and Continuance of Operations | |
The Company was incorporated on June 15, 1998 in the State of Nevada, USA and the Company’s common shares are publicly traded on the OTC Bulletin Board. | ||
Up until fiscal 2014, the Company was in the business of mineral exploration. On May 28, 2014, the Company formalized an agreement whereby it purchased assets associated with a smokeless cannabis delivery system. The Company plans to develop this system for commercial purposes. | ||
These consolidated interim financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next twelve months. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. At September 30, 2014, the Company had not yet achieved profitable operations, has accumulated losses of $416,701 since its inception and expects to incur further losses in the development of its business, all of which casts substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but considers that the Company will be able to obtain additional funds by equity financing and/or related party advances, however there is no assurance of additional funding being available. |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 9 Months Ended | ||
Sep. 30, 2014 | |||
Accounting Policies [Abstract] | ' | ||
Summary of Significant Accounting Policies | ' | ||
Note 3 | Summary of Significant Accounting Policies | ||
a) | Year end | ||
The Company has elected a December 31 st fiscal year end. | |||
b) | Cash and cash equivalents | ||
The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. As at September 30, 2014, the Company did not have any cash equivalents (2013 – $nil), and $0 was deposited in accounts that were federally insured (2013 - $0). | |||
c) | Revenue Recognition | ||
The Company recognizes revenue when a contract is in place, minerals are delivered to the purchaser and collectability is reasonably assured. | |||
d) | Stock-Based Compensation | ||
The Company follows the guideline under FASB ASC Topic 718 “Compensation-Stock Compensation” for all stock based compensation plans, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights. Stock compensation expenses are to be recorded using the fair value method. | |||
e) | Basic and Diluted Net Income (Loss) per Share | ||
The Company reports basic loss per share in accordance FASB ASC Topic 260, “Earnings per share”. Basic net income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. | |||
f) | Comprehensive Income | ||
In accordance with FASB ASC Topic 220 “Comprehensive Income,” comprehensive income consists of net income and other gains and losses affecting stockholder’s equity that are excluded from net income, such as unrealized gains and losses on investments available for sale, foreign currency translation gains and losses and minimum pension liability. | |||
g) | Use of Estimates | ||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results may ultimately differ from the estimates. Management believes such estimates to be reasonable. | |||
h) | Fair Value Measurements | ||
The Company follows FASB ASC 820, “Fair Value Measurements and Disclosures”, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. The Company has adopted FASB ASC 825, “Financial Instruments”, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Company has not elected the fair value option for any eligible financial instruments. | |||
i) | Financial Instruments | ||
Fair Value | |||
The fair value of the convertible notes payable is based on their beneficial conversion feature at the time of commitment, which requires allocation of the instrument between the host debt and the embedded equity component. Based on the intrinsic value of the conversion feature, the total value of the instruments was allocated to the equity component and included in additional paid-in capital. The balance of nil was allocated to the host debt. | |||
The resulting discounts are being amortized to income over 60 months. | |||
The fair value of the technology received and the shares issued has been determined in accordance with FASB ASC Topic 845 “Nonmonetary Transactions”. The basis for the value of the transaction is the determination of the value of shares issued as this is more clearly evident than the value of the technology. The share value of $.01, $.005, and $.045 per share has been used for the last 6 years for the convertible debt issued. | |||
Risks: | |||
Financial instruments that potentially subject the Company to credit risk consist principally of cash. Management does not believe the Company is exposed to significant credit risk. | |||
Management, as well, does not believe the Company is exposed to significant interest rate risks during the Period presented in these financial statements. | |||
The accompanying financial statements do not include any adjustments that might result from the eventual outcome of the risks and uncertainties described above. | |||
j) | Income Taxes | ||
The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. In estimating future tax consequences, all expected future events other than enactment of changes in the tax laws or rates are considered. | |||
Due to the uncertainty regarding the Company’s future profitability, the future tax benefits of its losses have been fully reserved. | |||
k) | Impairment of Long-Lived Assets | ||
Impairment losses on long-lived assets, such as technology assets , are recognized when events or changes in circumstances indicate that the undiscounted cash flows estimated to be generated by such assets are less than their carrying value and, accordingly, all or a portion of such carrying value may not be recoverable. Impairment losses are then measured by comparing the fair value of assets to their carrying amounts. | |||
l) | Foreign Currency Translation and Transactions | ||
The Company’s functional currency is US dollars. Foreign currency balances are translated into US dollars as follows: | |||
Monetary assets and liabilities are translated at the period-end exchange rate. Non-monetary assets are translated at the rate of exchange in effect at their acquisition, unless such assets are carried at market or nominal value, in which case they are translated at the period-end exchange rate. Revenue and expense items are translated at the average exchange rate for the period. Foreign exchange gains and losses in the period are included in operations | |||
The functional currency of the wholly owned subsidiary is Canadian dollars. The assets and liabilities arising from these operations are translated at current exchange rates and related revenues and expenses at the exchange rates in effect at the time the revenue or expense is incurred. Resulting translation adjustments, if material, are accumulated as a separate component of accumulated other comprehensive income in the statement of stockholders’ deficiency while foreign currency transaction gains and losses are included in operations. | |||
m) | Technology assets | ||
Technology assets are capitalized in accordance with ASC Topic 350-40 “Intangibles – Goodwill and Other.” The assets will be amortized, based on their estimated useful life once the assets are put into use. | |||
n) | Consolidation | ||
The consolidated financial statements include the accounts of the Company and its subsidiary, Scout Resources Inc. All significant inter-company balances and transactions have been eliminated. | |||
o) | Derivative Instruments | ||
The Financial Accounting Standards Board issued Statement of Financial Accounting Standards (“SFAS”) No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended by SFAS No. 137, “Accounting for Derivative Instruments and Hedging Activities – Deferral of the Effective Date of FASB No. 133”, SFAS No. 138, “Accounting for Certain Derivative Instruments and Certain Hedging Activities”, and SFAS No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities”, which is effective for the Company as of its inception. These statements establish accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. They require that an entity recognize all derivatives as either assets or liabilities in the balance sheet and measure those instruments at fair value. | |||
If certain conditions are met, a derivative may be specifically designated as a hedge, the objective of which is to match the timing of gain or loss recognition on the hedging derivative with the recognition of (i) the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk or (ii) the earnings effect of the hedged forecasted transaction. For a derivative not designated as a hedging instrument, the gain or loss is recognized in income in the period of change. The Company has not entered into derivative contracts to hedge existing risks or for speculative purposes. | |||
p) | Recent Accounting Pronouncements | ||
In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-10, “Development Stage Entities (Topic 915), Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, “Consolidation” (“ASU 2014-10”). The amendments in ASU 2014-10 remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from accounting principles generally accepted in the United States of America (“U.S. GAAP”). In addition, the amendments eliminate the requirements for development stage entities to: (i) present inception-to-date information in the statements of income, cash flows, and shareholder equity; (ii) label the financial statements as those of a development stage entity; (iii) disclose a description of the development stage activities in which the entity is engaged; and (iv) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The presentation and disclosure requirements in ASC Topic 915, “Development Stage Entities” are no longer required for interim and annual reporting periods beginning after December 15, 2014. The revised consolidation standards will take effect in annual periods beginning after December 15, 2015, however, early adoption is permitted. The Company has elected not to early adopt the provisions of ASU 2014-10 for these financial statements. |
Technology_Assets
Technology Assets | 9 Months Ended | |
Sep. 30, 2014 | ||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |
Technology Assets | ' | |
Note 4 | Technology Assets | |
On May 28, 2014, the Company finalized the asset purchase of the ‘CannaStrips’ technology – a smokeless cannabis delivery technology. – by authorizing the issue of 5,000,000 restricted shares at a value of $.01 each. However, the shares have not yet been issued, as the Company is awaiting regularly approval with respect to earlier filings. |
Notes_Payable
Notes Payable | 9 Months Ended | ||
Sep. 30, 2014 | |||
Notes Payable [Abstract] | ' | ||
Notes Payable | ' | ||
Note 5 | Notes Payable | ||
The Company has two notes payable to Paleface Holdings Inc. Each note is unsecured and payable on demand. | |||
a) | $25,000 note with annual interest payable at 8%. | ||
As at September 30, 2014, accrued interest on the note was $19,297 (September 30, 2013 - $17,297). The note payable balance including accrued interest was $44,297 as at September 30, 2014 (September 30, 2013 - $42,297). Interest on the debt for each of the years ended December 31 was $2,000. | |||
b) | $26,423 ($30,000 CDN) with annual interest payable at 5% | ||
As at September 30, 2014, accrued interest on the note was $10,972 (September 30, 2013 - $8,927). The note payable balance including accrued interest was $36,968 as at September 30, 2014 (September 30, 2013 - $38,850). Interest on debt for the nine months ended September 30 was $717 in 2014 and $1,088 in 2013. | |||
The company has an unsecured note payable on demand, bearing interest at 12% per annum to Gens Incognito Inc. for $25.000. As at September 30, 2014, accrued interest on the note was $953 (September 30, 2013 - $0). The note payable balance including accrued interest was $25,953 as at September 30, 2014 (September 30, 2013 - $0) |
Related_Party_Advances
Related Party Advances | 9 Months Ended | |
Sep. 30, 2014 | ||
Related Party Transactions [Abstract] | ' | |
Related Party Advances | ' | |
Note 6 | Related Party Advances | |
In 2008 the President advanced the Company $561 repayable without interest or any other terms. The unpaid balance as at September 30, 2014 is $261. There were no related party transactions in the nine months ended September 30, 2014. |
Common_Stock
Common Stock | 9 Months Ended | |
Sep. 30, 2014 | ||
Equity [Abstract] | ' | |
Common Stock | ' | |
Note 7 | Common Stock | |
On June 15, 1998 the Company authorized and issued 53,750,000 shares of its common stock in consideration of $430 in cash. ($.000008 per share.) | ||
On June 7, 2004 the Company issued 59,070,000 shares in consideration of $472 in cash. ($.000008 per share.) | ||
On June 14, 2001 the Company approved a forward stock split of 5,000:1. These financial statements have been retroactively adjusted to effect this split. | ||
On March 30, 2006 the Company entered into a private placement agreement whereby the Company issued 200,000 Regulation-S shares in exchange for $50,000. ($.25 per share) | ||
On May 28, 2014 the Company authorized for issue 5,000,000 restricted shares for the technology assets known as “CannaStrips.” The shares have not yet been issued as the Company is awaiting regularly approval. | ||
There are no shares subject to warrants, options or other agreements as September 30, 2014. |
Convertible_Note_Payable
Convertible Note Payable | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Debt Disclosure [Abstract] | ' | ||||||||
Convertible Note Payable | ' | ||||||||
Note 8 | Convertible Note Payable | ||||||||
There are four convertible notes payable which are non-interest bearing, unsecured and payable on demand. At any time prior to repayment any portion or the entire note may be converted into common stock at the discretion of the holder on the basis of $0.01 of debt to 1 share. The effect that conversion would have on earnings per share has not been disclosed due to the current anti-dilutive effect. | |||||||||
The balance of the first convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 40,000 | $ | 40,000 | |||||
Value allocated to additional paid-in capital | 40,000 | 40,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 40,000 | 40,000 | |||||||
Balance, convertible note payable | $ | 40,000 | $ | 40,000 | |||||
The total discount of $40,000 was amortized over 5 years starting April, 2008. | |||||||||
The balance of the second convertible note is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 20,000 | $ | 20,000 | |||||
Value allocated to additional paid-in capital | 20,000 | 20,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 17,000 | 14,000 | |||||||
Balance, convertible note payable | $ | 17,000 | $ | 14,000 | |||||
The total discount of $20,000 is being amortized over 5 years starting June 2010. Accordingly, the annual interest rate is 20% and for the nine months ended September 30, 2014 and 2013, $3,000 was recorded as interest expense. As at September 30, 2014, the unamortized discount was $3,000. | |||||||||
The balance of the third convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 10,000 | $ | 10,000 | |||||
Value allocated to additional paid-in capital | 10,000 | 10,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 7,000 | 5,500 | |||||||
Balance, convertible note payable | $ | 7,000 | $ | 5,500 | |||||
The total discount of $10,000 is being amortized over 5 years starting April, 2011. Accordingly, the annual interest rate is 20% and for the nine months ended September 30, 2014 and 2013, $1,500 was recorded as interest expense. As at September 30, 2014, the unamortized discount was $3,000. | |||||||||
The balance of the fourth convertible note payable at is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 25,000 | $ | 25,000 | |||||
Value allocated to additional paid-in capital | 25,000 | 25,000 | |||||||
Balance allocated to convertible note payable | - | ||||||||
Amortized discount | 7,500 | 3,750 | |||||||
Balance, convertible note payable | $ | 7,500 | $ | 3,750 | |||||
The total discount of $25,000 is being amortized over 5 years starting April, 2013. Accordingly, the annual interest rate is 20% and for the nine months ended September 30, 2014 $3,750 was recorded as interest expense. As at September 30, 2014 the unamortized discount was $17,500. | |||||||||
There are two convertible notes payable which are non-interest bearing, unsecured and payable on demand. At any time prior to repayment any portion or the entire note may be converted into common stock at the discretion of the holder on the basis of $0.005 of debt to 1 share. The effect that conversion would have on earnings per share has not been disclosed due to the current anti-dilutive effect | |||||||||
The balance of the first convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 10,000 | $ | 10,000 | |||||
Value allocated to additional paid-in capital | 10,000 | 10,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 6,750 | 5,250 | |||||||
Balance, convertible note payable | $ | 6,750 | $ | 5,250 | |||||
The total discount of $10,000 is being amortized over 5 years starting May, 2011. Accordingly, the annual interest rate is 20% and for the nine months ended September 30, 2014 and 2013, $1,500 was recorded as interest expense. As at September 30, 2014, the unamortized discount was $3,250. | |||||||||
The balance of the second convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 25,000 | $ | 25,000 | |||||
Value allocated to additional paid-in capital | 25,000 | 25,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 11,250 | 7,500 | |||||||
Balance, convertible note payable | $ | 11,250 | $ | 7,500 | |||||
The total discount of $25,000 is being amortized over 5 years starting July, 2012. Accordingly, the annual interest rate is 20% and for the nine months ended September 30, 2014 and 2013 3,750 was recorded as interest expense. As at September 30, 2014 the unamortized discount was $12,500. | |||||||||
There is one convertible note payable which is non-interest bearing, unsecured and payable on demand. At any time prior to repayment any portion or the entire note may be converted into common stock at the discretion of the holder on the basis of $0.045 of debt to 1 share. The effect that conversion would have on earnings per share has not been disclosed due to the current anti-dilutive effect. | |||||||||
The balance of this convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 25,000 | $ | - | |||||
Value allocated to additional paid-in capital | 25,000 | - | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 2,083 | - | |||||||
Balance, convertible note payable | $ | 2,083 | $ | - | |||||
The total discount of $25,000 is being amortized over 5 years starting May, 2013. Accordingly, the annual interest rate is 20% and for the nine months ended September 30, 2014 $2,033 was recorded as interest expense. As at September 30, 2014 the unamortized discount was $22,917. |
Financial_Statement_Presentati
Financial Statement Presentation | 9 Months Ended | |
Sep. 30, 2014 | ||
Accounting Policies [Abstract] | ' | |
Financial Statement Presentation | ' | |
Note 9 | Financial Statement Presentation | |
Certain prior year accounts have been reclassified to conform with the presentation used in 2013. |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 9 Months Ended | ||
Sep. 30, 2014 | |||
Accounting Policies [Abstract] | ' | ||
Year End | ' | ||
a) | Year end | ||
The Company has elected a December 31 st fiscal year end. | |||
Cash and Cash Equivalents | ' | ||
b) | Cash and cash equivalents | ||
The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. As at September 30, 2014, the Company did not have any cash equivalents (2013 – $nil), and $0 was deposited in accounts that were federally insured (2013 - $0). | |||
Revenue Recognition | ' | ||
c) | Revenue Recognition | ||
The Company recognizes revenue when a contract is in place, minerals are delivered to the purchaser and collectability is reasonably assured. | |||
Stock-Based Compensation | ' | ||
d) | Stock-Based Compensation | ||
The Company follows the guideline under FASB ASC Topic 718 “Compensation-Stock Compensation” for all stock based compensation plans, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights. Stock compensation expenses are to be recorded using the fair value method. | |||
Basic and Diluted Net Income (Loss) Per Share | ' | ||
e) | Basic and Diluted Net Income (Loss) per Share | ||
The Company reports basic loss per share in accordance FASB ASC Topic 260, “Earnings per share”. Basic net income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. | |||
Comprehensive Income | ' | ||
f) | Comprehensive Income | ||
In accordance with FASB ASC Topic 220 “Comprehensive Income,” comprehensive income consists of net income and other gains and losses affecting stockholder’s equity that are excluded from net income, such as unrealized gains and losses on investments available for sale, foreign currency translation gains and losses and minimum pension liability. | |||
Use of Estimates | ' | ||
g) | Use of Estimates | ||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results may ultimately differ from the estimates. Management believes such estimates to be reasonable. | |||
Fair Value Measurements | ' | ||
h) | Fair Value Measurements | ||
The Company follows FASB ASC 820, “Fair Value Measurements and Disclosures”, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. The Company has adopted FASB ASC 825, “Financial Instruments”, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Company has not elected the fair value option for any eligible financial instruments. | |||
Financial Instruments | ' | ||
i) | Financial Instruments | ||
Fair Value | |||
The fair value of the convertible notes payable is based on their beneficial conversion feature at the time of commitment, which requires allocation of the instrument between the host debt and the embedded equity component. Based on the intrinsic value of the conversion feature, the total value of the instruments was allocated to the equity component and included in additional paid-in capital. The balance of nil was allocated to the host debt. | |||
The resulting discounts are being amortized to income over 60 months. | |||
The fair value of the technology received and the shares issued has been determined in accordance with FASB ASC Topic 845 “Nonmonetary Transactions”. The basis for the value of the transaction is the determination of the value of shares issued as this is more clearly evident than the value of the technology. The share value of $.01, $.005, and $.045 per share has been used for the last 6 years for the convertible debt issued. | |||
Risks: | |||
Financial instruments that potentially subject the Company to credit risk consist principally of cash. Management does not believe the Company is exposed to significant credit risk. | |||
Management, as well, does not believe the Company is exposed to significant interest rate risks during the Period presented in these financial statements. | |||
The accompanying financial statements do not include any adjustments that might result from the eventual outcome of the risks and uncertainties described above. | |||
Income Taxes | ' | ||
j) | Income Taxes | ||
The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. In estimating future tax consequences, all expected future events other than enactment of changes in the tax laws or rates are considered. | |||
Due to the uncertainty regarding the Company’s future profitability, the future tax benefits of its losses have been fully reserved. | |||
Impairment of Long-Lived Assets | ' | ||
k) | Impairment of Long-Lived Assets | ||
Impairment losses on long-lived assets, such as technology assets , are recognized when events or changes in circumstances indicate that the undiscounted cash flows estimated to be generated by such assets are less than their carrying value and, accordingly, all or a portion of such carrying value may not be recoverable. Impairment losses are then measured by comparing the fair value of assets to their carrying amounts. | |||
Foreign Currency Translation and Transactions | ' | ||
l) | Foreign Currency Translation and Transactions | ||
The Company’s functional currency is US dollars. Foreign currency balances are translated into US dollars as follows: | |||
Monetary assets and liabilities are translated at the period-end exchange rate. Non-monetary assets are translated at the rate of exchange in effect at their acquisition, unless such assets are carried at market or nominal value, in which case they are translated at the period-end exchange rate. Revenue and expense items are translated at the average exchange rate for the period. Foreign exchange gains and losses in the period are included in operations | |||
The functional currency of the wholly owned subsidiary is Canadian dollars. The assets and liabilities arising from these operations are translated at current exchange rates and related revenues and expenses at the exchange rates in effect at the time the revenue or expense is incurred. Resulting translation adjustments, if material, are accumulated as a separate component of accumulated other comprehensive income in the statement of stockholders’ deficiency while foreign currency transaction gains and losses are included in operations. | |||
Technology assets | ' | ||
m) | Technology assets | ||
Technology assets are capitalized in accordance with ASC Topic 350-40 “Intangibles – Goodwill and Other.” The assets will be amortized, based on their estimated useful life once the assets are put into use. | |||
Consolidation | ' | ||
n) | Consolidation | ||
The consolidated financial statements include the accounts of the Company and its subsidiary, Scout Resources Inc. All significant inter-company balances and transactions have been eliminated. | |||
Derivative Instruments | ' | ||
o) | Derivative Instruments | ||
The Financial Accounting Standards Board issued Statement of Financial Accounting Standards (“SFAS”) No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended by SFAS No. 137, “Accounting for Derivative Instruments and Hedging Activities – Deferral of the Effective Date of FASB No. 133”, SFAS No. 138, “Accounting for Certain Derivative Instruments and Certain Hedging Activities”, and SFAS No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities”, which is effective for the Company as of its inception. These statements establish accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. They require that an entity recognize all derivatives as either assets or liabilities in the balance sheet and measure those instruments at fair value. | |||
If certain conditions are met, a derivative may be specifically designated as a hedge, the objective of which is to match the timing of gain or loss recognition on the hedging derivative with the recognition of (i) the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk or (ii) the earnings effect of the hedged forecasted transaction. For a derivative not designated as a hedging instrument, the gain or loss is recognized in income in the period of change. The Company has not entered into derivative contracts to hedge existing risks or for speculative purposes. | |||
Recent Accounting Pronouncements | ' | ||
p) | Recent Accounting Pronouncements | ||
In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-10, “Development Stage Entities (Topic 915), Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, “Consolidation” (“ASU 2014-10”). The amendments in ASU 2014-10 remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from accounting principles generally accepted in the United States of America (“U.S. GAAP”). In addition, the amendments eliminate the requirements for development stage entities to: (i) present inception-to-date information in the statements of income, cash flows, and shareholder equity; (ii) label the financial statements as those of a development stage entity; (iii) disclose a description of the development stage activities in which the entity is engaged; and (iv) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The presentation and disclosure requirements in ASC Topic 915, “Development Stage Entities” are no longer required for interim and annual reporting periods beginning after December 15, 2014. The revised consolidation standards will take effect in annual periods beginning after December 15, 2015, however, early adoption is permitted. The Company has elected not to early adopt the provisions of ASU 2014-10 for these financial statements. |
Convertible_Note_Payable_Table
Convertible Note Payable (Tables) | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Debt Disclosure [Abstract] | ' | ||||||||
Schedule of Convertible Notes Payable | ' | ||||||||
The balance of the first convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 40,000 | $ | 40,000 | |||||
Value allocated to additional paid-in capital | 40,000 | 40,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 40,000 | 40,000 | |||||||
Balance, convertible note payable | $ | 40,000 | $ | 40,000 | |||||
The balance of the second convertible note is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 20,000 | $ | 20,000 | |||||
Value allocated to additional paid-in capital | 20,000 | 20,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 17,000 | 14,000 | |||||||
Balance, convertible note payable | $ | 17,000 | $ | 14,000 | |||||
The balance of the third convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 10,000 | $ | 10,000 | |||||
Value allocated to additional paid-in capital | 10,000 | 10,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 7,000 | 5,500 | |||||||
Balance, convertible note payable | $ | 7,000 | $ | 5,500 | |||||
The balance of the fourth convertible note payable at is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 25,000 | $ | 25,000 | |||||
Value allocated to additional paid-in capital | 25,000 | 25,000 | |||||||
Balance allocated to convertible note payable | - | ||||||||
Amortized discount | 7,500 | 3,750 | |||||||
Balance, convertible note payable | $ | 7,500 | $ | 3,750 | |||||
The balance of the first convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 10,000 | $ | 10,000 | |||||
Value allocated to additional paid-in capital | 10,000 | 10,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 6,750 | 5,250 | |||||||
Balance, convertible note payable | $ | 6,750 | $ | 5,250 | |||||
The balance of the second convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 25,000 | $ | 25,000 | |||||
Value allocated to additional paid-in capital | 25,000 | 25,000 | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 11,250 | 7,500 | |||||||
Balance, convertible note payable | $ | 11,250 | $ | 7,500 | |||||
The balance of this convertible note payable is as follows: | |||||||||
30-Sep-14 | 31-Dec-13 | ||||||||
Balance | |||||||||
Proceeds from promissory note | $ | 25,000 | $ | - | |||||
Value allocated to additional paid-in capital | 25,000 | - | |||||||
Balance allocated to convertible note payable | - | - | |||||||
Amortized discount | 2,083 | - | |||||||
Balance, convertible note payable | $ | 2,083 | $ | - |
Nature_and_Continuance_of_Oper1
Nature and Continuance of Operations (Details Narrative) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' | ' |
Accumulated losses | $416,701 | $358,560 |
Summary_of_Significant_Account2
Summary of Significant Accounting Policies (Details Narrative) (USD $) | 9 Months Ended | |
Sep. 30, 2014 | Dec. 31, 2013 | |
Accounting Policies [Abstract] | ' | ' |
Cash equivalents | $0 | $0 |
Federally insured amount | $0 | $0 |
Amortization period of discount | '60 months | ' |
Convertible debt issued, share value per share description | ' | ' |
The share value of $.01, $.005, and $.045 per share has been used for the last 6 years for the convertible debt issued. |
Technology_Assets_Details_Narr
Technology Assets (Details Narrative) (USD $) | 28-May-14 |
Goodwill and Intangible Assets Disclosure [Abstract] | ' |
Shares authorized to issue restricted shares | 5,000,000 |
Restricted shares, par value | $0.01 |
Notes_Payable_Details_Narrativ
Notes Payable (Details Narrative) (USD $) | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 |
Gens Incognito Inc [Member] | Gens Incognito Inc [Member] | Notes Payable Annual Interest Payable At 8% [Member] | Notes Payable Annual Interest Payable At 8% [Member] | Notes Payable Annual Interest Payable At 8% [Member] | Notes Payable Annual Interest Payable At 5% [Member] | Notes Payable Annual Interest Payable At 5% [Member] | Notes Payable Annual Interest Payable At 5% [Member] | |
CDN [Member] | ||||||||
Notes payable | ' | ' | $25,000 | ' | ' | $26,423 | ' | $30,000 |
Annual interest payable | ' | ' | 8.00% | ' | ' | 5.00% | ' | ' |
Accrued interest on note | 953 | 0 | 19,297 | ' | 17,297 | 10,972 | 8,927 | ' |
Notes payable balance including accrued interest | 25,953 | 0 | 44,297 | ' | 42,297 | 36,968 | 38,850 | ' |
Interest on debt | ' | ' | ' | 2,000 | ' | 717 | 1,088 | ' |
Unsecured note payable | $25,000 | ' | ' | ' | ' | ' | ' | ' |
Unsecured note payable interest percentage | 12.00% | ' | ' | ' | ' | ' | ' | ' |
Related_Party_Advances_Details
Related Party Advances (Details Narrative) (President [Member], USD $) | Sep. 30, 2014 | Dec. 31, 2008 |
President [Member] | ' | ' |
Related party advance due | ' | $561 |
Related party unpaid balance | $261 | ' |
Common_Stock_Details_Narrative
Common Stock (Details Narrative) (USD $) | 0 Months Ended | ||||
Mar. 30, 2006 | Jun. 07, 2004 | Jun. 14, 2001 | Jun. 17, 1998 | 28-May-14 | |
Equity [Abstract] | ' | ' | ' | ' | ' |
Common shares issued for cash, shares | ' | 59,070,000 | ' | 53,750,000 | ' |
Common shares issued for cash | ' | $472 | ' | $430 | ' |
Issuance of stock, price per share | $0.25 | $0.00 | ' | $0.00 | ' |
Forward stock split ratio | ' | ' | ' | ' | ' |
forward stock split of 5,000:1 | |||||
Number of shares issued in private placement agreement | 200,000 | ' | ' | ' | ' |
Number of shares issued in private placement agreement exchange value | $50,000 | ' | ' | ' | ' |
Shares authorized to issue restricted shares | ' | ' | ' | ' | 5,000,000 |
Convertible_Note_Payable_Detai
Convertible Note Payable (Details Narrative) (USD $) | 9 Months Ended | 195 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | |
Amortization of debt discount | $15,583 | $14,250 | $91,583 |
First Convertible Note Payable [Member] | ' | ' | ' |
Debt conversion price for 1 share | 0.01 | ' | ' |
Amortization of debt discount | 40,000 | 40,000 | ' |
Amortization period of discount | '5 years | '5 years | ' |
Second Convertible Note Payable One [Member] | ' | ' | ' |
Amortization of debt discount | 20,000 | 20,000 | ' |
Amortization period of discount | '5 years | '5 years | ' |
Annual interest rate of debt | 20.00% | 20.00% | ' |
Interest expense | 3,000 | 3,000 | ' |
Unamortized discount | 3,000 | ' | 3,000 |
Third Convertible Note Payable [Member] | ' | ' | ' |
Amortization of debt discount | 10,000 | 10,000 | ' |
Amortization period of discount | '5 years | '5 years | ' |
Annual interest rate of debt | 20.00% | 20.00% | ' |
Interest expense | 1,500 | 1,500 | ' |
Unamortized discount | 3,000 | ' | 3,000 |
Fourth Convertible Note Payable [Member] | ' | ' | ' |
Debt conversion price for 1 share | 0.005 | ' | ' |
Amortization of debt discount | 25,000 | 25,000 | ' |
Amortization period of discount | '5 years | '5 years | ' |
Annual interest rate of debt | 20.00% | 20.00% | ' |
Interest expense | 3,750 | 3,750 | ' |
Unamortized discount | 17,500 | ' | 17,500 |
First Convertible Note Payable Two [Member] | ' | ' | ' |
Amortization of debt discount | 10,000 | 10,000 | ' |
Amortization period of discount | '5 years | '5 years | ' |
Annual interest rate of debt | 20.00% | 20.00% | ' |
Interest expense | 1,500 | 15,000 | ' |
Unamortized discount | 3,250 | ' | 3,250 |
Second Convertible Note Payable Two [Member] | ' | ' | ' |
Debt conversion price for 1 share | 0.045 | ' | ' |
Amortization of debt discount | 25,000 | 25,000 | ' |
Amortization period of discount | '5 years | '5 years | ' |
Annual interest rate of debt | 20.00% | 20.00% | ' |
Interest expense | 3,750 | 3,750 | ' |
Unamortized discount | 12,500 | ' | 12,500 |
Convertible Note Payable [Member] | ' | ' | ' |
Amortization of debt discount | 25,000 | ' | ' |
Amortization period of discount | '5 years | ' | ' |
Annual interest rate of debt | 20.00% | ' | ' |
Interest expense | 2,033 | ' | ' |
Unamortized discount | $22,917 | ' | $22,917 |
Convertible_Note_Payable_Sched
Convertible Note Payable - Schedule of Convertible Notes Payable (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
First Convertible Note Payable [Member] | ' | ' |
Proceeds from promissory note | $40,000 | $40,000 |
Value allocated to additional paid-in capital | 40,000 | 40,000 |
Balance allocated to convertible note payable | 0 | 0 |
Amortized discount | 40,000 | 40,000 |
Balance, convertible note payable | 40,000 | 40,000 |
Second Convertible Note Payable One [Member] | ' | ' |
Proceeds from promissory note | 20,000 | 20,000 |
Value allocated to additional paid-in capital | 20,000 | 20,000 |
Balance allocated to convertible note payable | 0 | 0 |
Amortized discount | 17,000 | 14,000 |
Balance, convertible note payable | 17,000 | 14,000 |
Third Convertible Note Payable [Member] | ' | ' |
Proceeds from promissory note | 10,000 | 10,000 |
Value allocated to additional paid-in capital | 10,000 | 10,000 |
Balance allocated to convertible note payable | 0 | 0 |
Amortized discount | 7,000 | 5,500 |
Balance, convertible note payable | 7,000 | 5,500 |
Fourth Convertible Note Payable [Member] | ' | ' |
Proceeds from promissory note | 25,000 | 25,000 |
Value allocated to additional paid-in capital | 25,000 | 25,000 |
Balance allocated to convertible note payable | 0 | 0 |
Amortized discount | 7,500 | 3,750 |
Balance, convertible note payable | 7,500 | 3,750 |
First Convertible Note Payable Two [Member] | ' | ' |
Proceeds from promissory note | 10,000 | 10,000 |
Value allocated to additional paid-in capital | 10,000 | 10,000 |
Balance allocated to convertible note payable | 0 | 0 |
Amortized discount | 6,750 | 5,250 |
Balance, convertible note payable | 6,750 | 5,250 |
Second Convertible Note Payable Two [Member] | ' | ' |
Proceeds from promissory note | 25,000 | 25,000 |
Value allocated to additional paid-in capital | 25,000 | 25,000 |
Balance allocated to convertible note payable | 0 | 0 |
Amortized discount | 11,250 | 7,500 |
Balance, convertible note payable | 11,250 | 7,500 |
Convertible Note Payable [Member] | ' | ' |
Proceeds from promissory note | 25,000 | ' |
Value allocated to additional paid-in capital | 25,000 | ' |
Balance allocated to convertible note payable | 0 | ' |
Amortized discount | 2,083 | ' |
Balance, convertible note payable | $2,083 | ' |